SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial OfficerPRNewsWire • 11/05/24
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024PRNewsWire • 10/22/24
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024PRNewsWire • 09/14/24
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy TestingPRNewsWire • 09/10/24
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024PRNewsWire • 09/05/24
SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024PRNewsWire • 09/04/24
SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth ConferencePRNewsWire • 08/28/24
SOPHiA GENETICS (SOPH) Loses -30.47% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 08/12/24
SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/06/24
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™PRNewsWire • 07/29/24
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024PRNewsWire • 07/23/24
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient CarePRNewsWire • 05/30/24